Improved outcome in solitary bone plasmacytomata with combined therapy

Hematological Oncology

Volumn 14, Issue 3, 1996, Pages 111-117

  Avilés, Agustin ^a,b   Huerta Guzmán, Judith ^a   Delgado, Serahn ^a   Fernández, Armando ^a   Díaz Maqueo, José C ^b  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b NONE

Author keywords

chemotherapy; melphalan; plasma cell dyscrasias; radiotherapy; solitary bone plasmacytomata

Indexed keywords

MELPHALAN; PREDNISONE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BONE TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PLASMACYTOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIFE TABLES; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; PLASMACYTOMA; PREDNISONE; PROSPECTIVE STUDIES; REMISSION INDUCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0030440458     PISSN: 02780232     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1069(199609)14:3<111::AID-HON575>3.0.CO;2-G     Document Type: Article

References (17)

1. Mill, W. B., Griffith, R. The role of radiation therapy in the management of plasma cell tumors. Cancer 1980, 45, 647-652.
2. Delauche, C. M. C., Laredo, J. C., Wybier, M., et al. Solitary plasmacytomata of the spine. Cancer 1988, 61, 1707-1714.
3. Jackson, A., Scarfee, J. H. Prognostic significance of osteopenia and immunoparesis at presentation of patients with solitary myeloma of bone. Eur. J. Cancer 1990, 26, 363-371.
4. Frassica, D. A., Frassica, F. J., Schray, M., Sin, F. H., Kyle, R. A. Solitary plasmacytomata of bone. Mayo Clinic experience. Int. J Radial. Oncol. Biol. Phys. 1989, 16, 43-48.
5. Knowling, M. A., Harwood, A. R., Bersagel, D. E. Comparison of extramedullary plasmacytomata with solitary and multiple plasma cell tumors of bone. J. Clin. Oncol. 1983, 1, 255-262.
6. Kapadia, S. B., Desai, V., Cheng, V. S. Extramedullary plasmacytomata of the head and neck. Medicine 1982, 61, 317-329.
7. Bataille, R., Sany, J. Solitary myeloma. Clinical and prognostic features of a review of 114 cases. Cancer 1981, 48, 845-851.
8. Dimopoulos, M. A., Goldstein, J., Fuller, L. M., Delasalle, K., Alexanian, R. Curability of solitary bone plasmacytomata. J. Clin. Oncol. 1992, 10, 587-590.
9. Avilés, A., Díaz-Maqueo, J. C., García, E. L., Guzmán, R., Talavera, A. Plasmocitoma solitario. Un análisis retrospectivo de 51 casos. Rev. Invest. Clin. 1990, 42, 277-280.
10. Avilés, A., Huerta, J., Zepeda, G., Díaz-Maqueo, J. C. Serum beta 2 microglobulin in solitary plasmacytomata (Letter). Blood 1990, 70, 1663-1664.
11. Chronic Leukemia Myeloma Task Force, National Cancer Institute. Proposal guidelines for protocol studies. II Plasma cell myeloma. Cancer Chemother. Rep. 1973, 4, 145-158.
12. Avilés, A., Díaz-Maqueo, J. C., Guzmán, R., Talavera, A. Mieloma múltiple. Un análisis retrospectivo de 486 casos. Rev. Méd. IMSS 1991, 28, 137-141.
13. Avilés, A., Zepeda, G., Guzmán, R. Importancia pronóstica de la beta 2 microglobulina en mieloma múltiple. Rev. Invest. Clin. 1992, 44, 215-220.
14. Avilés, A., Alatriste, S., Talavera, A., Delgado, S., Rosas, A. Alternating chemotherapy and interferon improves survival in poor prognosis multiple myeloma. Clin. Oncol. 1995, 7, 97-101.
15. Cox, D. R. Regression models and life tables. J. R. Stat. Assoc. 1972, 34, 183-220.
16. Kaplan, E., Meier, P. Non parametric estimation from incomplete observations. J. Am. Stat. Assoc. 1957, 53, 457-482.
17. Avilés, A., Díaz-Maqueo, J. C., Ayala, J. R., Córtes, H. D. Hodgkin's disease and acute leukaemia. It is a true association? Arch. Med. Res. 1992, 23, 65-68.